Search results
5 days ago · The President’s commitment to a clean energy economy has spurred $29 billion in public and private sector biomanufacturing investments for projects across the country since the start of the...
23 hours ago · It could be a flip of a coin. Craig Venter[0] almost patented what was back then the human reference genome (based on his own genome), but thankfully publicly funded efforts prevailed to taper the profiteering. We could be in a similar situation with anti-aging drugs.
4 days ago · Abstract. The use of single cell/nucleus RNA sequencing (scRNA-seq) technologies that quantitively describe cell transcriptional phenotypes is revolutionizing our understanding of cell biology, leading to new insights in cell type identification, disease mechanisms, and drug development.
It was aphantasia that he credits for his conceptual thinking. What was most interesting to me was that Venter discovered early on that he had aphantasia. I didn't know other people could actually visualise until a couple of years ago, so I'm obviously not as smart as he is - ha ha.
4 days ago · In summary, the study identified critical genetic biomarkers and successfully developed a novel disease risk prediction model for CKD. This model can serve as a valuable tool for CKD disease risk assessment and contribute significantly to CKD identification.
2 days ago · In 2014, biologist Craig Venter founded Human Longevity Inc., a company dedicated to scientific research to end aging through genomics and cell therapy. They received funding with the goal of compiling a comprehensive human genotype, microbiome, and phenotype database.
5 days ago · Craig Venter: Oceans of Genes May 14, 2024 Aboard his 100 ft sailboat, the geneticist famed for his work deciphering human genes spent 15 years sailing the world’s oceans, discovering millions of unknown genes in the microbes that live there – genes that could lead to new sources of energy, food and medicine.
